3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip
Open accessThe DOI matches its Crossref record; 199 of the 200 references it cites were found in a registry or an index; 79 of the 184 sources its claims cite were checked for support.
Abstract
Decades of efforts in engineering in vitro cancer models have advanced drug discovery and the insight into cancer biology. However, the establishment of preclinical models that enable fully recapitulating the tumor microenvironment remains challenging owing to its intrinsic complexity. Recent progress in engineering techniques has allowed the development of a new generation of in vitro preclinical models that can recreate complex in vivo tumor microenvironments and accurately predict drug responses, including spheroids, organoids, and tumor-on-a-chip. These biomimetic 3D tumor models are of particular interest as they pave the way for better understanding of cancer biology and accelerating the development of new anticancer therapeutics with reducing animal use. Here, the recent advances in developing these in vitro platforms for cancer modeling and preclinical drug screening, focusing on incorporating hydrogels are reviewed to reconstitute physiologically relevant microenvironments. The combination of spheroids/organoids with microfluidic technologies is also highlighted to better mimic in vivo tumors and discuss the challenges and future directions in the clinical translation of such models for drug screening and personalized medicine.
Overview
CoChat Summary
## TL;DR
This paper is a review of 3D biomimetic in vitro cancer models—spheroids, organoids, and tumor-on-a-chip—aimed at better reconstituting the tumor microenvironment (TME) for cancer biology and drug screening. It argues that these models can better capture ECM, hypoxia, interstitial flow, and multicellular interactions than 2D culture, while highlighting challenges for clinical translation and personalized medicine.
## Key findings
- The paper states that 2D monolayer models cannot recreate the complex tumor microenvironment, and that animal models are low throughput, time-consuming, costly, and limited by murine physiology; it notes that less than 4% of anticancer drug candidates pass clinical trials to FDA approval.
- 3D tumor spheroids can exceed 400 µm and develop in vivo-like oxygen/nutrient gradients with a necrotic core, quiescent intermediate region, and proliferating outer shell; they also replicate cell–cell interactions and de novo ECM deposition, and are used for routine drug screening.
- Patient-derived organoids preserve structural and functional features of in vivo tumors and, in one cited platform, supported organoid culture from over 1000 patients; organoids and organoids-on-a-chip are described as promising for predicting patient-specific drug responses.
- Microfluidic tumor-on-a-chip systems are presented as especially useful for modeling metastasis, angiogenesis, BBB transport, and therapy response because they can control fluid flow, multiple cell types, and microenvironmental cues; one BBB nanoparticle transport platform was reported to be faster than a 2D transwell setup (5 min vs 3 h).
## Methods
- Narrative review of recent advances in engineered 3D cancer models, organized around TME components, spheroids, organoids, and tumor-on-a-chip platforms.
- The paper synthesizes examples from prior studies using hydrogel-based systems, microfluidic devices, 3D bioprinting, microwell arrays, and coculture models with cancer, stromal, immune, endothelial, and BBB-related cells.
- It qualitatively compares model features and applications for cancer progression, metastasis, and anticancer drug screening rather than presenting new experimental data.
## Limitations
- The paper states that current 3D models still have limitations before widespread use, including incomplete incorporation of tumor vasculature, limited reproducibility, difficulty with long-term culture, and lack of scalability to high-throughput screening.
- It also states that many models do not fully capture the native TME because of nonstandardized or ill-defined matrices such as Matrigel, insufficient tissue-specific biochemical/biophysical cues, and lack of stromal or immune components.
- Evident from the text: this is a review article, so it does not generate new primary data or directly validate the summarized platforms in a single experimental system.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Spheroid models. a) PDMS‐based microwell arrays for culturing tumor spheroids to monitor the interactions among tumor spheroids, immune cells, and immune checkpoint inhibitors. Reproduced with permission.[ 58 ] Copyright 2021, Wiley‐VCH GmbH. b) Schematic illustration of the fabrication of hydrogel‐based microwell arrays for studying the effect of substrate composition and stiffness on tumor formation. Reproduced with permission.[ 60a ] Copyright 2017, IOP Publishing. c) Spheroids generated in a droplet‐based microfluidic platform for drug‐based cytotoxicity screening (p < 0.05). Reproduced with permission.[ 67 ] Copyright 2016, Royal Society of Chemistry. d) Hybrid hydrogel of collagen and alginate for fabrication of tumor spheroids for drug screening. Reproduced with permission.[ 72 ] Copyright 2017, American Chemical Society. e) Decellularized matrix for preparation of tumor spheroids for high‐throughput drug screening. Scalebars = 400 µm. Reproduced with permission.[ 78 ] Copyright 2021, Elsevier. f) Spheroids‐on‐a‐chip for studying the role of vascular perfusion in drug efficacy. Reproduced with permission.[ 81 ] Copyright 2020, Elsevier.](https://figures.cochat.ai/paper-figures/155e535488174a2fbe294a679725f9a0/3d-biomimetic-models-to-reconstitute-tumor-microenvironment-in-vitro-spheroids-figure-3.jpg)
![Figure 4 Organoid models. a) Schematic illustration of PDX‐derived tumor organoid encapsulated in enzymatically crosslinked HA‐Ph, gelatin‐Ph, or gelatin‐Ph/HA‐Ph hybrid hydrogels with tunable stiffness. Scale bars:100 µm. Reproduced with permission.[ 94 ] Copyright 2019, Elsevier. b) Schematics of ECM‐mimetic EKGel for growth of breast PDOs. Reproduced with permission.[ 96 ] Copyright 2022, Springer Nature. c) Microfluidic‐based organoid culture for drug sensitivity testing. Reproduced with permission.[ 103 ] Copyright 2019, Royal Society of Chemistry. d) Vascularized organoids chips for mimicking physiological delivery of drug to tumor sites. Scale bars:100 µm. Reproduced with permission.[ 104 ] Copyright 2019, Royal Society of Chemistry.](https://figures.cochat.ai/paper-figures/8bd4e1d098ef4dcb8bd82d144e7ecdb1/3d-biomimetic-models-to-reconstitute-tumor-microenvironment-in-vitro-spheroids-figure-4.jpg)
![Figure 5 Microfluidic modeling of tumor metastasis. a) A microfluidic‐based platform for capturing vasculogenic and angiogenic vessel formation. Scale bars:100 µm. Reproduced with permission.[ 112 ] Copyright 2013, Royal Society of Chemistry. b) Microfluidic lumen‐based system for reconstituting angiogenesis in response to different proangiogenic factors. Scale bars:100 µm. Reproduced with permission.[ 114c ] Copyright 2013, National Academy of Sciences. c) Organotypic microfluidic device for investigating tumor invasion in the presence of CAFs. Reproduced with permission.[ 117 ] Copyright 2019, American Association for Cancer Research. d) Schematics of tumor‐immune microenvironment in vitro: tumor spheroids are cocultured with neutrophils separated by porous membrane. Reproduced with permission.[ 123 ]Copyright 2021, IOP Publishing. e) Hydrogel‐based microfluidic platform modeling tumor intravasation. Reproduced with permission.[ 127 ] Copyright 2012, National Academy of Sciences. f) A 3D vascularized microfluidic device replicating the effect of monocytes on tumor cell extravasation. Reproduced with permission.[ 128 ] Copyright 2018, Elsevier.](https://figures.cochat.ai/paper-figures/f1f927abc8bd49949099b861c5abac18/3d-biomimetic-models-to-reconstitute-tumor-microenvironment-in-vitro-spheroids-figure-5.jpg)
![Figure 6 Microfluidic modeling of tumor response to therapeutics. a) Microfluidic invasion model that captures the crosstalk between tumor cells and CAFs for anticancer drug studies. Scale bar is 125 µm. Reproduced with permission.[ 135 ] Copyright 2017, Royal Society of Chemistry. b) Schematics of oxygen gradient‐array microfluidic device for studying the effect of oxygen levels on drug cytotoxicity in tumor spheroids. Reproduced with permission.[ 68a ] Copyright 2021, IOP Publishing. c) Illustration of microfluidic arrays to generate PDOs for developing personalized cancer therapies. Reproduced with permission.[ 106 ] Copyright 2021, Wiley‐VCH GmbH. d) Microfluidic lumen‐based system for evaluating anti‐angiogenesis treatment in RCC patients. Reproduced with permission.[ 138 ] Copyright 2019, Elsevier. e) Tumor‐vasculature‐on a‐chip for drug‐loaded nanoparticles evaluation. Reproduced with permission.[ 144 ] Copyright 2018, American Chemical Society. f) 3D microfluidic cancer angiogenesis‐on‐a‐chip for RNAi‐based nanomedicine evaluation. Scale bar is 200 µm. Reproduced with permission.[ 116 ] Copyright 2021, American Chemical Society.](https://figures.cochat.ai/paper-figures/d7bbd9b41a4a4089a6f43cdefa2e6115/3d-biomimetic-models-to-reconstitute-tumor-microenvironment-in-vitro-spheroids-figure-6.jpg)
![Figure 7 Microfluidic modeling of blood–brain barrier. a) A 3D neurovascular microfluidic model consisting of HUVECs, rat neurons and astrocytes. Reproduced with permission.[ 147 ] Copyright 2017, Royal Society of Chemistry. b) A low permeability microfluidic BBB platform incorporating vascular networks and rat neural cells (neurons and astrocytes). Reproduced with permission.[ 148 ] Copyright 2017, Springer Nature. c) Schematic representation of a microfluidic brain angiogenesis model containing human brain endothelial cells and human neural cells. Scale bar = 100 µm. Reproduced with permission.[ 151 ] Copyright 2019, Wiley. d) Schematic view of 3D BBB microvascular network model mimicking the microvascular structure present in the brain environment. Scale bars:100 µm. Reproduced with permission.[ 152 ] Copyright 2018, Elsevier. e) Schematics of a 3D in vitro BBB microvascular model to study brain metastasis. Reproduced with permission.[ 134 ] Copyright 2021, American Association for the Advancement of Science. f) Microfluidic lumen‐based BBB model to evaluate drug response of GBM spheroids. Reproduced with permission.[ 159 ]Copyright 2021, Wiley‐VCH GmbH.](https://figures.cochat.ai/paper-figures/cbd6d44ead37449a878d8c521e06efa7/3d-biomimetic-models-to-reconstitute-tumor-microenvironment-in-vitro-spheroids-figure-7.jpg)
Verification
Claims the paper makes
23 Valid · 51 Not valid · 92 Not checked · 67 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“composite collagen‐alginate microcapsules laden with breast cancer cells (MCF‐7) were reported to create 3D vascularized tumor spheroids by suspending these core–shell microbeads inside an external stromal cell‐laden collagen matrix”
§ 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip > Strategies for Physiologically Relevant 3D Models > Spheroids
What the sources say
- Disputedcites [72] sourceExperimental — accuracy not yet measured
The Results section, “An efficient CTC assay for a unique clinical application” (page unavailable), says MCF-7 cells were seeded into tapered or cylindrical microwells to form clusters. The device description in Results identifies PDMS layers and microwell arrays, not collagen–alginate core–shell microbeads in a stromal collagen matrix. The reported culture method is therefore contrary to the one attributed to this paper. (LLM, conf=0.85)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“In addition, the efficacy of programmed cell death protein‐1 (PD‐1) checkpoint immunotherapy was also evaluated on a patient‐derived GBM‐on‐a‐chip model, which consisted of two peripheral regions for vascular growth and middle regions for GBM growth.”
§ 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip > Strategies for Physiologically Relevant 3D Models > Tumor‐on‐a‐Chip
What the sources say
- Disputedcites [160] sourceExperimental — accuracy not yet measured
The Conclusion describes a vascularized breast cancer cell extravasation model, not a patient-derived GBM-on-a-chip model. The Materials and Methods section on blocking and neutralization identifies IL-6R, IL-8R and MMP-3 inhibitors as the treatments tested, rather than PD-1 checkpoint immunotherapy. Page numbers are unavailable in our copy. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Vasculature lined with endothelial cells is essential for cancer growth and metastasis.[ 15 ]”
§ 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip > Overview of TME > Cellular Components
What the sources say
- Could not verifycites [15] sourceExperimental — accuracy not yet measured
The Hydrodynamic force section describes a co-culture model of endothelial and breast cancer cells used to study tumor angiogenesis. It does not say that endothelial-lined vasculature is essential for cancer growth or metastasis; searches for that assertion and for metastasis found no supporting passage. Page numbers were not available in our copy. (LLM, conf=0.74)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, there is a lack of systematic and comprehensive evaluation of these three kinds of tumor models, especially on the inclusion of ECM in cancer modeling.”
§ 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip > Introduction
What the sources say
- Could not verifycites [11] sourceExperimental — accuracy not yet measured
The Introduction discusses limitations of in vitro culture systems for hepatocellular carcinoma, and the Discussion focuses on a humanised mouse model and its immune microenvironment. Searches for spheroids, organoids, tumor-on-a-chip, extracellular matrix, and systematic evaluation found no passage addressing the claimed gap in evaluating those three models or their inclusion of ECM. No page numbers are available in our copy. (LLM, conf=0.74)
- Not checked — no full text of the sourcecites [12]
- Partly supportedcites [13] sourceExperimental — accuracy not yet measured
The “Limitations of organoids” section calls for standardized organoid protocols to enable comparison of results and for models that reflect extracellular-matrix effects. It does not say that systematic, comprehensive evaluation is lacking across spheroids, organoids, and tumor-on-a-chip, particularly with respect to ECM inclusion. (LLM, conf=0.78)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“However, such models are still unable to faithfully capture key aspects of the human tumor microenvironment (TME).[ 9 ]”
§ 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip > Introduction
What the sources say
- Could not verifycites [9] sourceExperimental — accuracy not yet measured
The Background and Discussion passages address 3D cell cultures and how they mimic aspects of tumors in vivo, not humanized mouse models. A search of our copy for humanized mouse models and their ability to capture the tumor microenvironment found no passage addressing that claim; page numbers were not available. (LLM, conf=0.74)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
133 more claims · 42 with their cited sources checked
Create a free account to see all 233 claims and to verify the 29 references still open.
- It may state two separate claims as one. 74
- Probably not a substantial claim. 35
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
van de Wetering, M., Francies, H. E., Francis, J. M., Bounova, G., Iorio, F., Pronk, A., van Houdt, W., van Gorp, J., Taylor-Weiner, A., Kester, L., et al. (2015) · Cell · doi:10.1016/j.cell.2015.03.053 · Cited by 2,408
Maeda, H., Nakamura, H., & Fang, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.002 · Cited by 2,376
High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222
Organoid models of human and mouse ductal pancreatic cancer
Boj, S. F., Hwang, C.-I., Baker, L. A., Chio, I. I. C., Engle, D. D., Corbo, V., Jager, M., Ponz-Sarvise, M., Tiriac, H., Spector, M. S., et al. (2015) · Cell · doi:10.1016/j.cell.2014.12.021 · Cited by 2,150
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
Vlachogiannis, G., Hedayat, S., Vatsiou, A., Jamin, Y., Fernández-Mateos, J., Khan, K., Lampis, A., Eason, K., Huntingford, I., Burke, R., et al. (2018) · Science · doi:10.1126/science.aao2774 · Cited by 2,096
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Rhim, A. D., Oberstein, P. E., Thomas, D. H., Mirek, E. T., Palermo, C. F., Sastra, S. A., Dekleva, E. N., Saunders, T., Becerra, C. P., Tattersall, I. W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.021 · Cited by 2,085
A living biobank of breast cancer organoids captures disease heterogeneity
Sachs, N., de Ligt, J., Kopper, O., Gogola, E., Bounova, G., Weeber, F., Balgobind, A. V., Wind, K., Gracanin, A., Begthel, H., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.010 · Cited by 1,973
Modeling Tissue Morphogenesis and Cancer in 3D
Yamada, K. M., & Cukierman, E. (2007) · Cell · doi:10.1016/j.cell.2007.08.006 · Cited by 1,751
DeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715
Estimation of clinical trial success rates and related parameters
Wong, C. H., Siah, K. W., & Lo, A. W. (2019) · Biostatistics · doi:10.1093/biostatistics/kxx069 · Cited by 1,585
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Gao, D., Vela, I., Sboner, A., Iaquinta, P. J., Karthaus, W. R., Gopalan, A., Dowling, C., Wanjala, J. N., Undvall, E. A., Arora, V. K., et al. (2014) · Cell · doi:10.1016/j.cell.2014.08.016 · Cited by 1,559
The updated landscape of tumor microenvironment and drug repurposing
Jin, M.-Z., & Jin, W.-L. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00280-x · Cited by 1,262
3D Cell Culture Systems: Advantages and Applications
Ravi, M., Paramesh, V., Kaviya, S. R., Anuradha, E., & Solomon, F. D. P. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24683 · Cited by 1,206
Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy
Mehta, G., Hsiao, A. Y., Ingram, M., Luker, G. D., & Takayama, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.045 · Cited by 1,172
Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy
Henke, E., Nandigama, R., & Ergün, S. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00160 · Cited by 1,142
Immunological hallmarks of stromal cells in the tumour microenvironment
Turley, S. J., Cremasco, V., & Astarita, J. L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3902 · Cited by 1,140
Lost in translation: animal models and clinical trials in cancer treatment.
(2014) · Europe PMC (PubMed Central) · Cited by 1,033
Discovery of Endothelial to Mesenchymal Transition as a Source for Carcinoma-Associated Fibroblasts
Zeisberg, E. M., Potenta, S., Xie, L., Zeisberg, M., & Kalluri, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-3127 · Cited by 1,011
Zhang, C., Samanta, D., Lu, H., Bullen, J. W., Zhang, H., Chen, I., He, X., & Semenza, G. L. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602883113 · Cited by 971
Central nervous system pericytes in health and disease
Winkler, E. A., Bell, R. D., & Zlokovic, B. V. (2011) · Nature Neuroscience · doi:10.1038/nn.2946 · Cited by 962
Cancer modeling meets human organoid technology
Tuveson, D., & Clevers, H. (2019) · Science · doi:10.1126/science.aaw6985 · Cited by 935
3D tumor spheroids: an overview on the tools and techniques used for their analysis
Costa, E. C., Moreira, A. F., de Melo-Diogo, D., Gaspar, V. M., Carvalho, M. P., & Correia, I. J. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.11.002 · Cited by 929
Three-dimensional culture systems in cancer research: Focus on tumor spheroid model
Nath, S., & Devi, G. R. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.03.013 · Cited by 919
Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
Yu, M., Bardia, A., Aceto, N., Bersani, F., Madden, M. W., Donaldson, M. C., Desai, R., Zhu, H., Comaills, V., Zheng, Z., et al. (2014) · Science · doi:10.1126/science.1253533 · Cited by 913
Modelling cancer in microfluidic human organs-on-chips
Sontheimer-Phelps, A., Hassell, B. A., & Ingber, D. E. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-018-0104-6 · Cited by 906
Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function
Zervantonakis, I. K., Hughes-Alford, S. K., Charest, J. L., Condeelis, J. S., Gertler, F. B., & Kamm, R. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210182109 · Cited by 872
Engineering of functional, perfusable 3D microvascular networks on a chip
Kim, S., Lee, H., Chung, M., & Jeon, N. L. (2013) · Lab on a Chip · doi:10.1039/c3lc41320a · Cited by 872
An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity
Kopper, O., de Witte, C. J., Lõhmussaar, K., Valle-Inclan, J. E., Hami, N., Kester, L., Balgobind, A. V., Korving, J., Proost, N., Begthel, H., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0422-6 · Cited by 834
In Vitro Expansion of Human Gastric Epithelial Stem Cells and Their Responses to Bacterial Infection
Bartfeld, S., Bayram, T., van de Wetering, M., Huch, M., Begthel, H., Kujala, P., Vries, R., Peters, P. J., & Clevers, H. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.09.042 · Cited by 820
Chaudhuri, O., Koshy, S. T., Branco da Cunha, C., Shin, J.-W., Verbeke, C. S., Allison, K. H., & Mooney, D. J. (2014) · Nature Materials · doi:10.1038/nmat4009 · Cited by 820
Spaeth, E. L., Dembinski, J. L., Sasser, A. K., Watson, K., Klopp, A., Hall, B., Andreeff, M., & Marini, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004992 · Cited by 807
Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation
Jeon, J. S., Bersini, S., Gilardi, M., Dubini, G., Charest, J. L., Moretti, M., & Kamm, R. D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417115112 · Cited by 723
Nunes, A. S., Barros, A. S., Costa, E. C., Moreira, A. F., & Correia, I. J. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.26845 · Cited by 721
Schrader, J., Gordon-Walker, T. T., Aucott, R. L., van Deemter, M., Quaas, A., Walsh, S., Benten, D., Forbes, S. J., Wells, R. G., & Iredale, J. P. (2011) · Hepatology · doi:10.1002/hep.24108 · Cited by 720
Campisi, M., Shin, Y., Osaki, T., Hajal, C., Chiono, V., & Kamm, R. D. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.014 · Cited by 718
Macrophage-Based Approaches for Cancer Immunotherapy
Anderson, N. R., Minutolo, N. G., Gill, S., & Klichinsky, M. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2990 · Cited by 698
Yi, H.-G., Jeong, Y. H., Kim, Y., Choi, Y.-J., Moon, H. E., Park, S. H., Kang, K. S., Bae, M., Jang, J., Youn, H., et al. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0363-x · Cited by 634
HIF-1 as a target for drug development
Giaccia, A., Siim, B. G., & Johnson, R. S. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1199 · Cited by 631
Organoids: A historical perspective of thinking in three dimensions
Simian, M., & Bissell, M. J. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201610056 · Cited by 620
Loessner, D., Stok, K. S., Lutolf, M. P., Hutmacher, D. W., Clements, J. A., & Rizzi, S. C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.064 · Cited by 602
Shweiki, D., Neeman, M., Itin, A., & Keshet, E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.768 · Cited by 599
(2002) · PubMed · Cited by 550
Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
Shree, T., Olson, O. C., Elie, B. T., Kester, J. C., Garfall, A. L., Simpson, K., Bell-McGuinn, K. M., Zabor, E. C., Brogi, E., & Joyce, J. A. (2011) · Genes & Development · doi:10.1101/gad.180331.111 · Cited by 541
Activation of fibroblasts in cancer stroma
Räsänen, K., & Vaheri, A. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.04.032 · Cited by 499
Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro
Nguyen, D.-H. T., Stapleton, S. C., Yang, M. T., Cha, S. S., Choi, C. K., Galie, P. A., & Chen, C. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221526110 · Cited by 493
Self-citationSoft fibrin gels promote selection and growth of tumorigenic cells
Liu, J., Tan, Y., Zhang, H., Zhang, Y., Xu, P., Chen, J., Poh, Y.-C., Tang, K., Wang, N., & Huang, B. (2012) · Nature Materials · doi:10.1038/nmat3361 · Cited by 468
Adriani, G., Ma, D., Pavesi, A., Kamm, R. D., & Goh, E. L. K. (2017) · Lab on a Chip · doi:10.1039/c6lc00638h · Cited by 443
Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids
Schuster, B., Junkin, M., Kashaf, S. S., Romero-Calvo, I., Kirby, K., Matthews, J., Weber, C. R., Rzhetsky, A., White, K. P., & Tay, S. (2020) · Nature Communications · doi:10.1038/s41467-020-19058-4 · Cited by 424
Eigenmann, D. E., Xue, G., Kim, K. S., Moses, A. V., Hamburger, M., & Oufir, M. (2013) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-10-33 · Cited by 421
3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions
Rodrigues, J., Heinrich, M. A., Teixeira, L. M., & Prakash, J. (2021) · Trends in Cancer · doi:10.1016/j.trecan.2020.10.009 · Cited by 405
High-throughput automated organoid culture via stem-cell aggregation in microcavity arrays
Brandenberg, N., Hoehnel, S., Kuttler, F., Homicsko, K., Ceroni, C., Ringel, T., Gjorevski, N., Schwank, G., Coukos, G., Turcatti, G., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0565-2 · Cited by 390
Riedl, A., Schlederer, M., Pudelko, K., Stadler, M., Walter, S., Unterleuthner, D., Unger, C., Kramer, N., Hengstschläger, M., Kenner, L., et al. (2016) · Journal of Cell Science · doi:10.1242/jcs.188102 · Cited by 389
Poltavets, V., Kochetkova, M., Pitson, S. M., & Samuel, M. S. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00431 · Cited by 377
Kim, S., Min, S., Choi, Y. S., Jo, S.-H., Jung, J. H., Han, K., Kim, J., An, S., Ji, Y. W., Kim, Y.-G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29279-4 · Cited by 375
Generation of Multicellular Tumor Spheroids with Microwell-Based Agarose Scaffolds for Drug Testing
Gong, X., Lin, C., Cheng, J., Su, J., Zhao, H., Liu, T., Wen, X., & Zhao, P. (2015) · PLOS ONE · doi:10.1371/journal.pone.0130348 · Cited by 373
Kelland, L. R. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.11.028 · Cited by 352
Dijkgraaf, E. M., Heusinkveld, M., Tummers, B., Vogelpoel, L. T. C., Goedemans, R., Jha, V., Nortier, J. W. R., Welters, M. J. P., Kroep, J. R., & van der Burg, S. H. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3542 · Cited by 346
The Role of the Extracellular Matrix in Cancer Stemness
Nallanthighal, S., Heiserman, J. P., & Cheon, D.-J. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00086 · Cited by 344
Tumor organoids: Opportunities and challenges to guide precision medicine
Veninga, V., & Voest, E. E. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.07.020 · Cited by 339
Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis
Mizutani, Y., Kobayashi, H., Iida, T., Asai, N., Masamune, A., Hara, A., Esaki, N., Ushida, K., Mii, S., Shiraki, Y., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0454 · Cited by 336
Vascularized cancer on a chip: the effect of perfusion on growth and drug delivery of tumor spheroid
Nashimoto, Y., Okada, R., Hanada, S., Arima, Y., Nishiyama, K., Miura, T., & Yokokawa, R. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2019.119547 · Cited by 332
Shirure, V. S., Bi, Y., Curtis, M. B., Lezia, A., Goedegebuure, M. M., Goedegebuure, S. P., Aft, R., Fields, R. C., & George, S. C. (2018) · Lab on a Chip · doi:10.1039/c8lc00596f · Cited by 316
Organoid Cultures as Preclinical Models of Non–Small Cell Lung Cancer
Shi, R., Radulovich, N., Ng, C., Liu, N., Notsuda, H., Cabanero, M., Martins-Filho, S. N., Raghavan, V., Li, Q., Mer, A. S., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1376 · Cited by 316
3D in vitro bioengineered tumors based on collagen I hydrogels
Szot, C. S., Buchanan, C. F., Freeman, J. W., & Rylander, M. N. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.001 · Cited by 306
Jeong, S.-Y., Lee, J.-H., Shin, Y., Chung, S., & Kuh, H.-J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0159013 · Cited by 287
Ma, X., Yu, C., Wang, P., Xu, W., Wan, X., Lai, C. S. E., Liu, J., Koroleva-Maharajh, A., & Chen, S. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.026 · Cited by 281
Xu, Z., Li, E., Guo, Z., Yu, R., Hao, H., Xu, Y., Sun, Z., Li, X., Lyu, J., & Wang, Q. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b08746 · Cited by 264
Melissaridou, S., Wiechec, E., Magan, M., Jain, M. V., Chung, M. K., Farnebo, L., & Roberg, K. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0733-1 · Cited by 262
(2001) · PubMed · Cited by 257
Grantab, R., Sivananthan, S., & Tannock, I. F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3077 · Cited by 254
Design of spherically structured 3D in vitro tumor models -Advances and prospects
Ferreira, L. P., Gaspar, V. M., & Mano, J. F. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.05.034 · Cited by 249
Bang, S., Lee, S.-R., Ko, J., Son, K., Tahk, D., Ahn, J., Im, C., & Jeon, N. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-07416-0 · Cited by 246
A microfluidics platform for combinatorial drug screening on cancer biopsies
Eduati, F., Utharala, R., Madhavan, D., Neumann, U. P., Longerich, T., Cramer, T., Saez-Rodriguez, J., & Merten, C. A. (2018) · Nature Communications · doi:10.1038/s41467-018-04919-w · Cited by 239
Paek, J., Park, S. E., Lu, Q., Park, K.-T., Cho, M., Oh, J. M., Kwon, K. W., Yi, Y.-S., Song, J. W., Edelstein, H. I., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b00686 · Cited by 238
A dynamic in vivo-like organotypic blood-brain barrier model to probe metastatic brain tumors
Xu, H., Li, Z., Yu, Y., Sizdahkhani, S., Ho, W. S., Yin, F., Wang, L., Zhu, G., Zhang, M., Jiang, L., et al. (2016) · Scientific Reports · doi:10.1038/srep36670 · Cited by 234
Patient-derived micro-organospheres enable clinical precision oncology
Ding, S., Hsu, C., Wang, Z., Natesh, N. R., Millen, R., Negrete, M., Giroux, N., Rivera, G. O., Dohlman, A., Bose, S., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.04.006 · Cited by 228
Microfluidic modelling of the tumor microenvironment for anti-cancer drug development
Shang, M., Soon, R. H., Lim, C. T., Khoo, B. L., & Han, J. (2019) · Lab on a Chip · doi:10.1039/c8lc00970h · Cited by 227
Self-citationKim, S., Chung, M., Ahn, J., Lee, S., & Jeon, N. L. (2016) · Lab on a Chip · doi:10.1039/c6lc00910g · Cited by 227
Advances in Microfluidic Blood–Brain Barrier (BBB) Models
Oddo, A., Peng, B., Tong, Z., Wei, Y., Tong, W. Y., Thissen, H., & Voelcker, N. H. (2019) · Trends in Biotechnology · doi:10.1016/j.tibtech.2019.04.006 · Cited by 221
Invasive three-dimensional organotypic neoplasia from multiple normal human epithelia
Ridky, T. W., Chow, J. M., Wong, D. J., & Khavari, P. A. (2010) · Nature Medicine · doi:10.1038/nm.2265 · Cited by 217
Breast cancer models: Engineering the tumor microenvironment
Bahcecioglu, G., Basara, G., Ellis, B. W., Ren, X., & Zorlutuna, P. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.02.006 · Cited by 213
3D bioprinted mammary organoids and tumoroids in human mammary derived ECM hydrogels
Mollica, P. A., Booth-Creech, E. N., Reid, J. A., Zamponi, M., Sullivan, S. M., Palmer, X.-L., Sachs, P. C., & Bruno, R. D. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.06.017 · Cited by 206
Zhao, Y., Shuen, T. W. H., Toh, T. B., Chan, X. Y., Liu, M., Tan, S. Y., Fan, Y., Yang, H., Lyer, S. G., Bonney, G. K., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315201 · Cited by 200
Below, C. R., Kelly, J., Brown, A., Humphries, J. D., Hutton, C., Xu, J., Lee, B. Y., Cintas, C., Zhang, X., Hernandez-Gordillo, V., et al. (2022) · Nature Materials · doi:10.1038/s41563-021-01085-1 · Cited by 194
Sabhachandani, P., Motwani, V., Cohen, N., Sarkar, S., Torchilin, V., & Konry, T. (2016) · Lab on a Chip · doi:10.1039/c5lc01139f · Cited by 193
An Automated Organoid Platform with Inter-organoid Homogeneity and Inter-patient Heterogeneity
Jiang, S., Zhao, H., Zhang, W., Wang, J., Liu, Y., Cao, Y., Zheng, H., Hu, Z., Wang, S., Zhu, Y., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100161 · Cited by 188
Charoen, K. M., Fallica, B., Colson, Y. L., Zaman, M. H., & Grinstaff, M. W. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.038 · Cited by 187
Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers
Murlidhar, V., Reddy, R. M., Fouladdel, S., Zhao, L., Ishikawa, M. K., Grabauskiene, S., Zhang, Z., Lin, J., Chang, A. C., Carrott, P., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2072 · Cited by 181
Targeting nanoparticles for diagnosis and therapy of bone tumors: Opportunities and challenges
Gao, X., Li, L., Cai, X., Huang, Q., Xiao, J., & Cheng, Y. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120404 · Cited by 180
Jeong, K., Yu, Y. J., You, J. Y., Rhee, W. J., & Kim, J. A. (2020) · Lab on a Chip · doi:10.1039/c9lc00958b · Cited by 178
A one-stop microfluidic-based lung cancer organoid culture platform for testing drug sensitivity
Jung, D. J., Shin, T. H., Kim, M., Sung, C. O., Jang, S. J., & Jeong, G. S. (2019) · Lab on a Chip · doi:10.1039/c9lc00496c · Cited by 176
Chitcholtan, K., Asselin, E., Parent, S., Sykes, P. H., & Evans, J. J. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.09.012 · Cited by 173
Khoo, B. L., Grenci, G., Lim, Y. B., Lee, S. C., Han, J., & Lim, C. T. (2018) · Nature Protocols · doi:10.1038/nprot.2017.125 · Cited by 172
Self-citationMicrofluidics Enabled Bottom-Up Engineering of 3D Vascularized Tumor for Drug Discovery
Agarwal, P., Wang, H., Sun, M., Xu, J., Zhao, S., Liu, Z., Gooch, K. J., Zhao, Y., Lu, X., & He, X. (2017) · ACS Nano · doi:10.1021/acsnano.7b00824 · Cited by 168
Cui, X., Ma, C., Vasudevaraja, V., Serrano, J., Tong, J., Peng, Y., Delorenzo, M., Shen, G., Frenster, J., Morales, R.-T. T., et al. (2020) · eLife · doi:10.7554/elife.52253 · Cited by 163
Tumor-Vasculature-on-a-Chip for Investigating Nanoparticle Extravasation and Tumor Accumulation
Wang, H.-F., Ran, R., Liu, Y., Hui, Y., Zeng, B., Chen, D., Weitz, D. A., & Zhao, C.-X. (2018) · ACS Nano · doi:10.1021/acsnano.8b06846 · Cited by 161
The effects of monocytes on tumor cell extravasation in a 3D vascularized microfluidic model
Boussommier-Calleja, A., Atiyas, Y., Haase, K., Headley, M., Lewis, C., & Kamm, R. D. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.005 · Cited by 158
Three-dimensional biomimetic model to reconstitute sprouting lymphangiogenesis in vitro
Kim, S., Chung, M., & Jeon, N. L. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.11.019 · Cited by 157
Vaquero, J., Guedj, N., Clapéron, A., Nguyen Ho-Bouldoires, T. H., Paradis, V., & Fouassier, L. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.09.010 · Cited by 154
Extracellular matrix alterations in senescent cells and their significance in tissue homeostasis
Mavrogonatou, E., Pratsinis, H., Papadopoulou, A., Karamanos, N. K., & Kletsas, D. (2019) · Matrix Biology · doi:10.1016/j.matbio.2017.10.004 · Cited by 153
Straehla, J. P., Hajal, C., Safford, H. C., Offeddu, G. S., Boehnke, N., Dacoba, T. G., Wyckoff, J., Kamm, R. D., & Hammond, P. T. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2118697119 · Cited by 152
Truong, D., Fiorelli, R., Barrientos, E. S., Melendez, E. L., Sanai, N., Mehta, S., & Nikkhah, M. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.048 · Cited by 150
Truong, D. D., Kratz, A., Park, J. G., Barrientos, E. S., Saini, H., Nguyen, T., Pockaj, B., Mouneimne, G., LaBaer, J., & Nikkhah, M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2293 · Cited by 149
Khoo, B. L., Grenci, G., Jing, T., Lim, Y. B., Lee, S. C., Thiery, J. P., Han, J., & Lim, C. T. (2016) · Science Advances · doi:10.1126/sciadv.1600274 · Cited by 147
Self-citationMicrofluidic Tumor–Vascular Model to Study Breast Cancer Cell Invasion and Intravasation
Nagaraju, S., Truong, D., Mouneimne, G., & Nikkhah, M. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701257 · Cited by 147
Three-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicine
Xie, F., Sun, L., Pang, Y., Xu, G., Jin, B., Xu, H., Lu, X., Xu, Y., Du, S., Wang, Y., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120416 · Cited by 147
Lee, J., Mehrotra, S., Zare‐Eelanjegh, E., Rodrigues, R. O., Akbarinejad, A., Ge, D., Amato, L., Kiaee, K., Fang, Y., Rosenkranz, A., et al. (2021) · Small · doi:10.1002/smll.202004258 · Cited by 143
Sleep deprivation and false confessions
Frenda, S. J., Berkowitz, S. R., Loftus, E. F., & Fenn, K. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521518113 · Cited by 138
Bioengineered 3D models of human pancreatic cancer recapitulate in vivo tumour biology
Osuna de la Peña, D., Trabulo, S. M. D., Collin, E., Liu, Y., Sharma, S., Tatari, M., Behrens, D., Erkan, M., Lawlor, R. T., Scarpa, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25921-9 · Cited by 138
Rapid 3D Bioprinting of Glioblastoma Model Mimicking Native Biophysical Heterogeneity
Tang, M., Tiwari, S. K., Agrawal, K., Tan, M. L., Dang, J. W., Tam, T., Tian, J., Wan, X., Schimelman, J. B., You, S., et al. (2021) · Small · doi:10.1002/smll.202006050 · Cited by 137
Breast Cancer Cell Invasion into a Three Dimensional Tumor-Stroma Microenvironment
Truong, D., Puleo, J., Llave, A., Mouneimne, G., Kamm, R. D., & Nikkhah, M. (2016) · Scientific Reports · doi:10.1038/srep34094 · Cited by 135
Recent Advances in Targeted Tumor Chemotherapy Based on Smart Nanomedicines
Qin, S., Zhang, A., & Zhang, X. (2018) · Small · doi:10.1002/smll.201802417 · Cited by 135
Biomimetic hydrogel supports initiation and growth of patient-derived breast tumor organoids
Prince, E., Cruickshank, J., Ba-Alawi, W., Hodgson, K., Haight, J., Tobin, C., Wakeman, A., Avoulov, A., Topolskaia, V., Elliott, M. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28788-6 · Cited by 135
LumeNEXT: A Practical Method to Pattern Luminal Structures in ECM Gels
Jiménez‐Torres, J. A., Peery, S. L., Sung, K. E., & Beebe, D. J. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201500608 · Cited by 132
3D brain angiogenesis model to reconstitute functional human blood–brain barrier in vitro
Lee, S., Chung, M., Lee, S., & Jeon, N. L. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27224 · Cited by 130
Endothelial Regulation of Drug Transport in a 3D Vascularized Tumor Model
Haase, K., Offeddu, G. S., Gillrie, M. R., & Kamm, R. D. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202002444 · Cited by 127
The hypoxic tumor microenvironment in vivo selects the cancer stem cell fate of breast cancer cells
Kim, H., Lin, Q., Glazer, P. M., & Yun, Z. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-0944-8 · Cited by 122
Microfluidic Arrays of Breast Tumor Spheroids for Drug Screening and Personalized Cancer Therapies
Prince, E., Kheiri, S., Wang, Y., Xu, F., Cruickshank, J., Topolskaia, V., Tao, H., Young, E. W. K., McGuigan, A. P., Cescon, D. W., et al. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202101085 · Cited by 121
Tumor-on-a-chip for integrating a 3D tumor microenvironment: chemical and mechanical factors
Wan, L., Neumann, C. A., & LeDuc, P. R. (2020) · Lab on a Chip · doi:10.1039/c9lc00550a · Cited by 120
Mao, S., He, J., Zhao, Y., Liu, T., Xie, F., Yang, H., Mao, Y., Pang, Y., & Sun, W. (2020) · Biofabrication · doi:10.1088/1758-5090/aba0c3 · Cited by 106
Willemse, J., van Tienderen, G., van Hengel, E., Schurink, I., van der Ven, D., Kan, Y., de Ruiter, P., Rosmark, O., Westergren-Thorsson G, G., Schneeberger, K., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121473 · Cited by 106
A 3D human renal cell carcinoma-on-a-chip for the study of tumor angiogenesis
Miller, C. P., Tsuchida, C., Zheng, Y., Himmelfarb, J., & Akilesh, S. (2018) · Neoplasia · doi:10.1016/j.neo.2018.02.011 · Cited by 105
Ng, S., Tan, W. J., Pek, M. M. X., Tan, M.-H., & Kurisawa, M. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119400 · Cited by 105
A pan-cancer organoid platform for precision medicine
Larsen, B. M., Kannan, M., Langer, L. F., Leibowitz, B. D., Bentaieb, A., Cancino, A., Dolgalev, I., Drummond, B. E., Dry, J. R., Ho, C.-S., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109429 · Cited by 105
Modeling Nanocarrier Transport across a 3D In Vitro Human Blood‐Brain–Barrier Microvasculature
Lee, S. W. L., Campisi, M., Osaki, T., Possenti, L., Mattu, C., Adriani, G., Kamm, R. D., & Chiono, V. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.201901486 · Cited by 104
Arya, A. D., Hallur, P. M., Karkisaval, A. G., Gudipati, A., Rajendiran, S., Dhavale, V., Ramachandran, B., Aravindakshan, J., Gundiah, N., & Chaubey, A. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b06309 · Cited by 103
Lugo-Cintrón, K. M., Gong, M. M., Ayuso, J. M., Tomko, L. A., Beebe, D. J., Virumbrales-Muñoz, M., & Ponik, S. M. (2020) · Cancers · doi:10.3390/cancers12051173 · Cited by 103
Piotrowski-Daspit, A. S., Tien, J., & Nelson, C. M. (2016) · Integrative Biology · doi:10.1039/c5ib00282f · Cited by 101
Li, R., Hebert, J. D., Lee, T. A., Xing, H., Boussommier-Calleja, A., Hynes, R. O., Lauffenburger, D. A., & Kamm, R. D. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-0442 · Cited by 100
Engineered Microsystems for Spheroid and Organoid Studies
Kang, S., Kim, D., Lee, J., Takayama, S., & Park, J. Y. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202001284 · Cited by 100
Surendran, V., Rutledge, D., Colmon, R., & Chandrasekaran, A. (2021) · Biofabrication · doi:10.1088/1758-5090/abe1cf · Cited by 99
Kim, J. H., Verwilst, P., Won, M., Lee, J., Sessler, J. L., Han, J., & Kim, J. S. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c03875 · Cited by 98
Yue, X., Nguyen, T. D., Zellmer, V., Zhang, S., & Zorlutuna, P. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.04.001 · Cited by 97
Kafashan, M., Jaffe, A. W., Chettih, S. N., Nogueira, R., Arandia-Romero, I., Harvey, C. D., Moreno-Bote, R., & Drugowitsch, J. (2021) · Nature Communications · doi:10.1038/s41467-020-20722-y · Cited by 96
Seo, S., Nah, S.-Y., Lee, K., Choi, N., & Kim, H. N. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202106860 · Cited by 94
Multiplexed drug testing of tumor slices using a microfluidic platform
Horowitz, L. F., Rodriguez, A. D., Dereli-Korkut, Z., Lin, R., Castro, K., Mikheev, A. M., Monnat, R. J., Folch, A., & Rostomily, R. C. (2020) · npj Precision Oncology · doi:10.1038/s41698-020-0117-y · Cited by 88
Zhou, Y., Wang, B., Wu, J., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2526-4 · Cited by 87
The potential of organoids in urological cancer research
Wang, S., Gao, D., & Chen, Y. (2017) · Nature Reviews Urology · doi:10.1038/nrurol.2017.65 · Cited by 87
Sabhachandani, P., Sarkar, S., Mckenney, S., Ravi, D., Evens, A. M., & Konry, T. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.010 · Cited by 87
Yamamoto, K., Makino, T., Sato, E., Noma, T., Urakawa, S., Takeoka, T., Yamashita, K., Saito, T., Tanaka, K., Takahashi, T., et al. (2020) · Cancer Science · doi:10.1111/cas.14328 · Cited by 85
Tissue invasive macrophage density is correlated with prognosis in cholangiocarcinoma
Wongkham (2010) · Molecular Medicine Reports · doi:10.3892/mmr_00000303 · Cited by 84
Facile One Step Formation and Screening of Tumor Spheroids Using Droplet‐Microarray Platform
Popova, A. A., Tronser, T., Demir, K., Haitz, P., Kuodyte, K., Starkuviene, V., Wajda, P., & Levkin, P. A. (2019) · Small · doi:10.1002/smll.201901299 · Cited by 84
Pleural Effusion Aspirate for Use in 3D Lung Cancer Modeling and Chemotherapy Screening
Mazzocchi, A., Devarasetty, M., Herberg, S., Petty, W. J., Marini, F., Miller, L., Kucera, G., Dukes, D. K., Ruiz, J., Skardal, A., et al. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b01356 · Cited by 82
Proteinaceous Hydrogels for Bioengineering Advanced 3D Tumor Models
Blanco‐Fernandez, B., Gaspar, V. M., Engel, E., & Mano, J. F. (2021) · Advanced Science · doi:10.1002/advs.202003129 · Cited by 78
A microfluidic platform for functional testing of cancer drugs on intact tumor slices
Rodriguez, A. D., Horowitz, L. F., Castro, K., Kenerson, H., Bhattacharjee, N., Gandhe, G., Raman, A., Monnat, R. J., Yeung, R., Rostomily, R. C., et al. (2020) · Lab on a Chip · doi:10.1039/c9lc00811j · Cited by 77
Enabling peristalsis of human colon tumor organoids on microfluidic chips
Fang, G., Lu, H., Al-Nakashli, R., Chapman, R., Zhang, Y., Ju, L. A., Lin, G., Stenzel, M. H., & Jin, D. (2022) · Biofabrication · doi:10.1088/1758-5090/ac2ef9 · Cited by 77
Peptide-protein Coassembling Matrices as a Biomimetic 3D Model of Ovarian Cancer
Hedegaard, C. L., Redondo-Gómez, C., Tan, B. Y., Ng, K. W., Loessner, D., & Mata, A. (2020) · Science Advances · doi:10.1126/sciadv.abb3298 · Cited by 76
3D hydrogel-based microwell arrays as a tumor microenvironment model to study breast cancer growth
Casey, J., Yue, X., Nguyen, T. D., Acun, A., Zellmer, V. R., Zhang, S., & Zorlutuna, P. (2017) · Biomedical Materials · doi:10.1088/1748-605x/aa5d5c · Cited by 74
Klimkiewicz, K., Weglarczyk, K., Collet, G., Paprocka, M., Guichard, A., Sarna, M., Jozkowicz, A., Dulak, J., Sarna, T., Grillon, C., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.006 · Cited by 70
Matrix Stiffness-Regulated Growth of Breast Tumor Spheroids and Their Response to Chemotherapy
Li, Y., Khuu, N., Prince, E., Tao, H., Zhang, N., Chen, Z., Gevorkian, A., McGuigan, A. P., & Kumacheva, E. (2021) · Biomacromolecules · doi:10.1021/acs.biomac.0c01287 · Cited by 69
The CCL2-CCR2 astrocyte-cancer cell axis in tumor extravasation at the brain
Hajal, C., Shin, Y., Li, L., Serrano, J. C., Jacks, T., & Kamm, R. D. (2021) · Science Advances · doi:10.1126/sciadv.abg8139 · Cited by 69
Adjei‐Sowah, E., O’Connor, S. A., Veldhuizen, J., Cascio, C. L., Plaisier, C. L., Mehta, S. V., & Nikkhah, M. (2022) · Advanced Science · doi:10.1002/advs.202201436 · Cited by 69
Hajal, C., Ibrahim, L., Serrano, J. C., Offeddu, G. S., & Kamm, R. D. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120470 · Cited by 68
Lee, S., Kim, S., Koo, D.-J., Yu, J., Cho, H., Lee, H., Song, J. M., Kim, S., Min, D., & Jeon, N. L. (2020) · ACS Nano · doi:10.1021/acsnano.0c05110 · Cited by 68
Yoshii, Y., Furukawa, T., Waki, A., Okuyama, H., Inoue, M., Itoh, M., Zhang, M.-R., Wakizaka, H., Sogawa, C., Kiyono, Y., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.008 · Cited by 66
Wang, M., Liu, Y., Cheng, Y., Wei, Y., & Wei, X. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.12.002 · Cited by 66
Microdissected “cuboids” for microfluidic drug testing of intact tissues
Horowitz, L. F., Rodriguez, A. D., Au-Yeung, A., Bishop, K. W., Barner, L. A., Mishra, G., Raman, A., Delgado, P., Liu, J. T. C., Gujral, T. S., et al. (2021) · Lab on a Chip · doi:10.1039/d0lc00801j · Cited by 62
Self-citationCancer‐on‐a‐Chip for Modeling Immune Checkpoint Inhibitor and Tumor Interactions
Jiang, X., Ren, L. M., Tebon, P. J., Wang, C., Zhou, X., Qu, M., Zhu, J., Ling, H., Zhang, S., Xue, Y., et al. (2021) · Small · doi:10.1002/smll.202004282 · Cited by 60
Self-citationOrganotypic 3D decellularized matrix tumor spheroids for high-throughput drug screening
Ferreira, L. P., Gaspar, V. M., Mendes, L., Duarte, I. F., & Mano, J. F. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120983 · Cited by 59
Oncology Drug Discovery: Planning a Turnaround
Toniatti, C., Jones, P., Graham, H., Pagliara, B., & Draetta, G. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0452 · Cited by 57
Li, H., Liu, P., Kaur, G., Yao, X., & Yang, M. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700185 · Cited by 56
Self-citationSinha, S., Ayushman, M., Tong, X., & Yang, F. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202202147 · Cited by 56
van Tienderen, G. S., Rosmark, O., Lieshout, R., Willemse, J., de Weijer, F., Elowsson Rendin, L., Westergren-Thorsson, G., Doukas, M., Groot Koerkamp, B., van Royen, M. E., et al. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.11.038 · Cited by 47
Jiménez-Torres, J. A., Virumbrales-Muñoz, M., Sung, K. E., Lee, M. H., Abel, E. J., & Beebe, D. J. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.026 · Cited by 46
Berger Fridman, I., Ugolini, G. S., VanDelinder, V., Cohen, S., & Konry, T. (2021) · Biofabrication · doi:10.1088/1758-5090/abdb88 · Cited by 46
Humayun, M., Ayuso, J. M., Brenneke, R. A., Virumbrales-Muñoz, M., Lugo-Cintrón, K., Kerr, S., Ponik, S. M., & Beebe, D. J. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120640 · Cited by 46
Lugo-Cintrón, K. M., Ayuso, J. M., Humayun, M., Gong, M. M., Kerr, S. C., Ponik, S. M., Harari, P. M., Virumbrales-Muñoz, M., & Beebe, D. J. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103634 · Cited by 45
Non-small cell lung carcinoma spheroid models in agarose microwells for drug response studies
Luan, Q., Becker, J. H., Macaraniag, C., Massad, M. G., Zhou, J., Shimamura, T., & Papautsky, I. (2022) · Lab on a Chip · doi:10.1039/d2lc00244b · Cited by 45
Ivanova, E., Kuraguchi, M., Xu, M., Portell, A. J., Taus, L., Diala, I., Lalani, A. S., Choi, J., Chambers, E. S., Li, S., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1844 · Cited by 43
Microfluidic system for modelling 3D tumour invasion into surrounding stroma and drug screening
Du, Z., Mi, S., Yi, X., Xu, Y., & Sun, W. (2018) · Biofabrication · doi:10.1088/1758-5090/aac70c · Cited by 42
On-Chip Replication of Extremely Early-Stage Tumor Behavior
Li, C., Li, S., Du, K., Li, P., Qiu, B., & Ding, W. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c03740 · Cited by 40
Rapid multilayer microfabrication for modeling organotropic metastasis in breast cancer
Kwak, T. J., & Lee, E. (2020) · Biofabrication · doi:10.1088/1758-5090/abbd28 · Cited by 39
Virumbrales-Muñoz, M., Chen, J., Ayuso, J., Lee, M., Abel, E. J., & Beebe, D. J. (2020) · Lab on a Chip · doi:10.1039/d0lc00252f · Cited by 39
Organotypic breast tumor model elucidates dynamic remodeling of tumor microenvironment
Singh, S. K., Ray, L. A., Thakuri, P. S., Tran, S. K., Konopka, M., Luker, G. D., & Tavana, H. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119853 · Cited by 38
Crippa, M., Bersini, S., Gilardi, M., Arrigoni, C., Gamba, S., Falanga, A., Candrian, C., Dubini, G., Vanoni, M., & Moretti, M. (2021) · Lab on a Chip · doi:10.1039/d0lc01011a · Cited by 37
The effects of biofilms on tumor progression in a 3D cancer-biofilm microfluidic model
Deng, Y., Liu, S. Y., Chua, S. L., & Khoo, B. L. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113113 · Cited by 36
Self-citationXia, Y., Chen, H., Li, J., Hu, H., Qian, Q., He, R.-X., Ding, Z., & Guo, S.-S. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c06655 · Cited by 35
Zhang, T., Deng, Y., Yang, S. L., Chua, S. L., Tang, B. Z., & Khoo, B. L. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.137579 · Cited by 31
Self-citationPeela, N., Barrientos, E. S., Truong, D., Mouneimne, G., & Nikkhah, M. (2017) · Integrative Biology · doi:10.1039/c7ib00180k · Cited by 29
A novel 3D vascular assay for evaluating angiogenesis across porous membranes
Bai, J., Haase, K., Roberts, J. J., Hoffmann, J., Nguyen, H. T., Wan, Z., Zhang, S., Sarker, B., Friedman, N., Ristić-Lehmann, Č., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120592 · Cited by 29
Goodarzi, S., Prunet, A., Rossetti, F., Bort, G., Tillement, O., Porcel, E., Lacombe, S., Wu, T.-D., Guerquin-Kern, J.-L., Delanoë-Ayari, H., et al. (2021) · Lab on a Chip · doi:10.1039/d1lc00192b · Cited by 29
Shin, Y., Lim, S., Kim, J., Jeon, J. S., Yoo, H., & Gweon, B. (2019) · Lab on a Chip · doi:10.1039/c9lc00352e · Cited by 26
Mathematical Modelling of the Effects of Mitotic Inhibitors on Avascular Tumour Growth
Ward, J., & King, J. R. (1998) · Computational and Mathematical Methods in Medicine · doi:10.1080/10273669908833027 · Cited by 25
Sun, W., Chen, Y., Wang, Y., Luo, P., Zhang, M., Zhang, H., & Hu, P. (2018) · The Analyst · doi:10.1039/c8an01216d · Cited by 25
Advances in bioengineering pancreatic tumor-stroma physiomimetic Biomodels
Monteiro, M. V., Ferreira, L. P., Rocha, M., Gaspar, V. M., & Mano, J. F. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121653 · Cited by 19
Lin, L., He, Z., Jie, M., Lin, J., & Zhang, J. (2021) · Talanta · doi:10.1016/j.talanta.2021.122702 · Cited by 18
Johnson, P. A., Menegatti, S., Chambers, A. C., Alibhai, D., Collard, T. J., Williams, A. C., Bayley, H., & Perriman, A. W. (2023) · Biofabrication · doi:10.1088/1758-5090/ac999f · Cited by 16
Li, W., Zhou, Y., Deng, Y., & Khoo, B. L. (2022) · Cancers · doi:10.3390/cancers14030818 · Cited by 15
Self-citationBoussommier-Calleja, A. (2020) · Bioengineering Innovative Solutions for Cancer · doi:10.1016/b978-0-12-813886-1.00013-9 · Cited by 10
Abstract 1700: Novel microfluidic blood-brain niche to study breast cancer metastasis to the brain
Altemus, M., Leung, B. M., Morikawa, A., et al. (2016) · Cancer Research · doi:10.1158/1538-7445.am2016-1700 · Cited by 4
Research works printed but not linked: 7
- Mak I. W., 2014, Am. J. Transl. Res., 6, 114
- Bates D. O., 2002, Cancer Res., 62, 4123
- Subimerb C., 2010, Mol. Med. Rep., 3, 597
- Milosevic M., 2001, Cancer Res., 61, 6400
- 10.1371/journal.pone.0159013 · DOI · Paper page
- 10.1016/j.biomaterials.2018.07.048 · DOI · Paper page
- Sinha S., 2022, Adv. Healthcare Mater.
Cited by
Alternatives of Animal Models for Biomedical Research: a Comprehensive Review of Modern Approaches
Vashishat, A., Patel, P., Gupta, G. D., & Kurmi, B. D. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-024-10701-x · Cited by 123
Shen, X., Pan, D., Gong, Q., Gu, Z., & Luo, K. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.10.017 · Cited by 131
“To pursue an animal model that mimics a complex and realistic physiological or pathological environment in patient [75], patient-derived xenograft (PDX) models have been developed, and they have a number of advantages.”
BackgroundAdvancements in wearable sensors for cardiovascular disease detection for health monitoring
Khan, B., Riaz, Z., Ahmad, R. U. S., & Khoo, B. L. (2024) · Materials Science and Engineering R Reports · doi:10.1016/j.mser.2024.100804 · Cited by 96
Self-citationTumor-on-a-chip models combined with mini-tissues or organoids for engineering tumor tissues
Hwangbo, H., Chae, S., Kim, W.-J., Jo, S., & Kim, G. (2023) · Theranostics · doi:10.7150/thno.90093 · Cited by 73
“The utilization of cell spheroids in Tumor-on-Chip (TOC) technology presents several notable limitations [110].”
BackgroundPredictive, preventive, and personalized medicine in breast cancer: targeting the PI3K pathway
Tufail, M., Hu, J.-J., Liang, J., He, C., Wan, W., Huang, Y., Jiang, C., Wu, H., & Li, N. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-023-04841-w · Cited by 80
“One of the major advantages of 3D orga-noids is their ability to recreate complex tumor micro-environments in a controlled laboratory environment [103].”
Background
Metadata
- Authors
- Li, W., Zhou, Z., Zhou, X., Khoo, B. L., Gunawan, R., Chin, Y. R., Zhang, L., Yi, C., Guan, X., & Yang, M.
- Affiliations
- City University of Hong Kong (HK)
- Sun Yat-sen University (CN)
- Department of Clinical Oncology State Key Laboratory for Liver Research The University of Hong Kong Hong Kong SAR 999077 China
- Corresponding author
- Yang, Mengsu
- ORCID
- Venue
- Advanced Healthcare Materials
- Publisher
- Wiley
- Published
- 2023-03-29
- Volume
- 12
- Issue
- 18
- Pages
- e2202609-e2202609
- ISSN
- 2192-2640 (ISSN-L)
- 2192-2659
- PMC
- PMC11468819
- OpenAlex
- W4324133297
- Cited by
- 119
- References
- 200
- Citations by year
- 2026: 36 · 2025: 44 · 2024: 33 · 2023: 6
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Advanced Healthcare Materials (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion, cc-by-nc-nd)
- CityU Scholars (submittedVersion, cc-by-nc)
- Funders
- Impact Fund
- City University of Hong Kong
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- tumor microenvironment, 3D tumor models, tumor spheroids, organoids, tumor-on-a-chip, biomimetic systems, hydrogels, microfluidics, preclinical drug screening, anticancer drug discovery, personalized medicine, animal-free model
- MeSH terms
- Animals, Neoplasms, Organoids, Spheroids, Cellular, Biomimetics, Lab-On-A-Chip Devices, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.